BIOG-B:STO
BioGaia AB
၁၂၂.၈၀ SEK
arrow_upward
+၀.၅၇%(+၀.၇၀) 1D
အောက် ၁၅, GMT+၂ ၁၇:၂၉:၃၃ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOG-B...
Open
၁၂၂.၈၀ SEK
High
၁၂၃.၆၀ SEK
Low
၁၂၁.၃၀ SEK
Mkt. cap
ဋေ ၁.၂၀ ထ
Avg. vol.
၁.၆၃ သိန်း
Volume
၂.၀၇ သိန်း
52-wk high
၁၃၆.၃၀ SEK
52-wk low
၉၆.၂၀ SEK
Shares outstanding
၉.၈၅ ကုဋေ
No. of employees
၂၅၁
Open
၁၂၂.၈၀ SEK
High
၁၂၃.၆၀ SEK
Low
၁၂၁.၃၀ SEK
Mkt. cap
ဋေ ၁.၂၀ ထ
Avg. vol.
၁.၆၃ သိန်း
Volume
၂.၀၇ သိန်း
52-wk high
၁၃၆.၃၀ SEK
52-wk low
၉၆.၂၀ SEK
Shares outstanding
၉.၈၅ ကုဋေ
No. of employees
၂၅၁
News stories
From web sources and news partners
TipRanks
·
ပြီးခဲ့သည့် ၁၀ နာရီ
BioGaia names Nomination Committee for 2027 AGM
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB